Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
28.34
-0.19 (-0.67%)
Jul 21, 2026, 10:46 AM EDT - Market open
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $2.78 billion as of July 21, 2026. Its market cap has increased by 11.87% in one year.
Market Cap
2.78B
Enterprise Value
3.47B
1-Year Change
11.87%
Ranking
Category
Stock Price
$28.34
ChartMarket Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $2.78B, an increase of 134.06%. That is a compound annual growth rate of 7.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 2.78B | 25.40% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 2.99B |
| Disc Medicine | 2.91B |
| Celldex Therapeutics | 2.77B |
| uniQure | 2.77B |
| Vera Therapeutics | 2.76B |
| Beam Therapeutics | 2.74B |
| Trevi Therapeutics | 2.71B |
| AtaiBeckley | 2.67B |